{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:10:48Z","timestamp":1787605848848,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to observe the effectiveness of botulinum toxin type A (BTA) in the treatment of intermittent exotropia (IXT) in children compared with strabismus surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One hundred forty-four children with a clear diagnosis of IXT and an indication for surgery were eligible for inclusion. Subjects were divided into two groups based on parental decision: the BTA injection group (injection group) or the conventional surgery group (surgery group). All cases were followed up for 6\u2009months. The primary outcome was a comparison of the success rate (deviation between \u2212\u200910 and\u2009+\u200910 PD) between the two groups at 6\u2009months after the initial treatment. Secondary outcomes included change in deviation, visual function, and post-surgical complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventy-two patients were enrolled in each group. At 6-month follow-up, there was no significant difference in the success rate between the injection and surgery groups (52.8% vs 66.7%, <jats:italic>P<\/jats:italic>\u2009=\u20090.13; postoperative deviation \u2212\u200912.22\u2009\u00b1\u200910.80 PD vs \u2212\u20099.17\u2009\u00b1\u200910.30 PD, <jats:italic>P<\/jats:italic>\u2009=\u20090.09). The binocular Visual function, except for near stereoacuity, improved after treatment in both groups, while the fusion recovery rate was higher in the surgical group (68.1% vs 95.8%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Transient complications in the injection group included diplopia, ptosis, and subconjunctival hemorrhage, whereas subconjunctival hemorrhage, conjunctival edema, foreign body sensation, pain, and diplopia were seen in the surgical group. The complications of BTA were relatively mild.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>BTA is as effective as surgery in the treatment of IXT in children, but the recovery of the fusion is lower than surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study has completed the clinical registration on (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=23698.\">ChiCTR-INR-17013777<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02285-2","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T16:29:22Z","timestamp":1643992162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of Botulinum toxin type A with surgery for the\u00a0treatment of intermittent exotropia in children"],"prefix":"10.1186","volume":"22","author":[{"given":"Han","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"issue":"10","key":"2285_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","volume":"87","author":"AB Scott","year":"1980","unstructured":"Scott AB. Botulinum toxin injection into Extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87(10):1044\u20139.","journal-title":"Ophthalmology."},{"issue":"1","key":"2285_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","volume":"52","author":"JJ Dutton","year":"2007","unstructured":"Dutton JJ, Fowler AM. Botulinum toxin in ophthalmology. Surv Ophthalmol. 2007;52(1):13\u201331.","journal-title":"Surv Ophthalmol"},{"issue":"23","key":"2285_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1080\/09638280701568189","volume":"29","author":"L Kowal","year":"2007","unstructured":"Kowal L, Wong E, Yahalom C. Botulinum toxin in the treatment of strabismus. A review of its use and effects. Disabil Rehabil. 2007;29(23):1823\u201331.","journal-title":"Disabil Rehabil"},{"issue":"7","key":"2285_CR4","first-page":"471","volume":"75","author":"DLSP G\u00f3mez","year":"2000","unstructured":"G\u00f3mez DLSP, D-MI V, DLSR G, Bonales DA, Rajadlsedo A. Treatment of sixth nerve palsy of traumatic or tumor etiology using botulinum toxin. Arch Soc Esp Oftalmol. 2000;75(7):471\u20136.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2285_CR5","first-page":"457","volume":"36","author":"O Yaba\u015f","year":"2006","unstructured":"Yaba\u015f O, Ziylan \u015e, Zorlutuna N. Botulinum toxin in acute sixth nerve palsy. Turk J Ophthalmol. 2006;36:457\u201361.","journal-title":"Turk J Ophthalmol"},{"issue":"8","key":"2285_CR6","first-page":"457","volume":"38","author":"X Wu","year":"2002","unstructured":"Wu X. Botulinum toxin a in treatment of the sixth cranial nerve palsy. Chin J Ophthalmol. 2002;38(8):457\u201361.","journal-title":"Chin J Ophthalmol."},{"key":"2285_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ajo.2016.12.024","volume":"176","author":"MJ Wan","year":"2017","unstructured":"Wan MJ, Mantagos IS, Shah AS, Kazlas M, Hunter DG. Comparison of Botulinum toxin with surgery for the treatment of acute-onset Comitant Esotropia in children. Am J Ophthalmol. 2017;176:33\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2285_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3928\/0191-3913-20001101-05","volume":"37","author":"EC Campos","year":"2000","unstructured":"Campos EC, Schiavi C, Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J Pediatr Ophthalmol Strabismus. 2000;37(6):328\u201332.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"2285_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ajo.2010.05.004","volume":"150","author":"JH Park","year":"2010","unstructured":"Park JH, Kim SH. Clinical features and the risk factors of infantile exotropia recurrence. Am J Ophthalmol. 2010;150(4):464\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2285_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/eye.2012.55","volume":"26","author":"SH Lim","year":"2012","unstructured":"Lim SH, Hwang BS, Kim MM. Prognostic factors for recurrence after bilateral rectus recession procedure in patients with intermittent exotropia. Eye (Lond). 2012;26(6):846\u201352.","journal-title":"Eye (Lond)"},{"issue":"11","key":"2285_CR11","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0161-6420(97)30029-3","volume":"104","author":"RF Spencer","year":"1997","unstructured":"Spencer RF, Tucker MG, Choi RY, McNeer KW. Botulinum toxin management of childhood intermittent Exotropia. Ophthalmology. 1997;104(11):1762\u20137.","journal-title":"Ophthalmology."},{"issue":"1","key":"2285_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaapos.2016.11.018","volume":"21","author":"D Zou","year":"2017","unstructured":"Zou D, Casafina C, Whiteman A, Jain S. Predictors of surgical success in patients with intermittent exotropia. J AAPOS. 2017;21(1):15\u20138.","journal-title":"J AAPOS"},{"issue":"11","key":"2285_CR13","first-page":"967","volume":"44","author":"Y Li","year":"2008","unstructured":"Li Y, Wu X. Observation of botulinum toxin a management in childhood with intermittent exotropia. Chin J Ophthalmol. 2008;44(11):967\u201371.","journal-title":"Chin J Ophthalmol"},{"issue":"4","key":"2285_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/09273972.2014.962750","volume":"22","author":"M Etezad Razavi","year":"2014","unstructured":"Etezad Razavi M, Sharifi M, Armanfar F. Efficacy of botulinum toxin in the treatment of intermittent exotropia. Strabismus. 2014;22(4):176\u201381.","journal-title":"Strabismus."},{"issue":"4","key":"2285_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/09273972.2016.1242639","volume":"24","author":"A Bruce","year":"2016","unstructured":"Bruce A, Santorelli G. Prevalence and risk factors of strabismus in a UK multi-ethnic birth cohort. Strabismus. 2016;24(4):153\u201360.","journal-title":"Strabismus."},{"issue":"7","key":"2285_CR16","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.ophtha.2006.01.033","volume":"113","author":"KJ Nusz","year":"2006","unstructured":"Nusz KJ, Mohney BG, Diehl NN. The course of intermittent exotropia in a population-based cohort. Ophthalmology. 2006;113(7):1154\u20138.","journal-title":"Ophthalmology."},{"issue":"11","key":"2285_CR17","first-page":"04","volume":"112","author":"M Govindan","year":"2005","unstructured":"Govindan M, Mohney BG, Diehl NN, Burke JP. Incidence and types of childhood exotropia: a population-based study. Ophthalmology. 2005;112(11):04\u2013108.","journal-title":"Ophthalmology."},{"issue":"1","key":"2285_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1034\/j.1600-0420.1998.760106.x","volume":"76","author":"G Lennerstrand","year":"1998","unstructured":"Lennerstrand G, Nordbo OA, Tian S. Treatment of strabismus and nystagmus with botulinum toxin type a, an evaluation of effects and complications. Acta Ophthalmol. 1998;76(1):27\u201337.","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"2285_CR19","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0161-6420(90)32390-4","volume":"97","author":"AB Scott","year":"1990","unstructured":"Scott AB, Magoon EH, McNeer KW, Stager DR. Botulinum treatment of childhood strabismus. Ophthalmology. 1990;97(11):1434\u20138.","journal-title":"Ophthalmology."},{"issue":"3","key":"2285_CR20","first-page":"528","volume":"7","author":"JY Lee","year":"2014","unstructured":"Lee JY, Ko SJ, Baek SU. Survival analysis following early surgical success in intermittent exotropia surgery. Int J Ophthalmol. 2014;7(3):528\u201333.","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"2285_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3928\/01913913-20201007-04","volume":"58","author":"RL Thorisdottir","year":"2021","unstructured":"Thorisdottir RL, Malmsj\u00f6 M, Tenland K, Blohm\u00e9 J, Hesgaard HB. The success of unilateral surgery for constant and intermittent Exotropia and factors affecting it in a large Scandinavian case series. J Pediatr Ophthalmol Strabismus. 2021;58(1):34\u201341.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2285_CR22","volume-title":"Altlas of strabismus diognosis and therapy","author":"W Lu","year":"2016","unstructured":"Lu W. In: Lu W, editor. Altlas of strabismus diognosis and therapy. Beijing: Science and Technology Press; 2016."},{"issue":"5","key":"2285_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3928\/0191-3913-20030901-10","volume":"40","author":"KW Mcneer","year":"2003","unstructured":"Mcneer KW, Tucker MG, Guerry CH, Spencer RF. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin a. PediatrOphthalmol Strabismus. 2003;40(5):288\u201392.","journal-title":"PediatrOphthalmol Strabismus"},{"key":"2285_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/0065955X.1988.11981779","volume":"38","author":"PM Edelman","year":"1988","unstructured":"Edelman PM, Brown MH, Murphee AL, Wright KW. Consecutive esodeviation, then what? Am Orthopt J. 1988;38:111\u20136.","journal-title":"Am Orthopt J"},{"issue":"1","key":"2285_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ophtha.2017.10.007","volume":"125","author":"DK Wallace","year":"2018","unstructured":"Wallace DK, Christiansen SP, Sprunger DT, Melia M, Lee KA, Morse CL, et al. Esotropia and Exotropia preferred practice pattern(R). Ophthalmology. 2018;125(1):143\u201383.","journal-title":"Ophthalmology."},{"key":"2285_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/jocd.12141","volume":"14","author":"LH Ricci","year":"2015","unstructured":"Ricci LH, Navajas SV, Carneiro PR, Sderberg SA, Ferraz CA. Ocular adverse effects after facial cosmetic procedures: a review of case reports. J Cosmet Dermatol. 2015;14:145\u201351.","journal-title":"J Cosmet Dermatol"},{"issue":"11","key":"2285_CR27","first-page":"1189","volume":"85","author":"S Tengtrisorn","year":"2002","unstructured":"Tengtrisorn S, Treyapun N, Tantisarasart T. Botulinum a toxin therapy on esotropia in children. Chotmaihet thangphaet. 2002;85(11):1189\u201397.","journal-title":"Chotmaihet thangphaet"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T16:29:32Z","timestamp":1643992172000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2285"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02285-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki. Ethics committee approval was obtained from the Institutional Review Board of Beijing Tongren Hospital, Capital Medical University (TRECKY2018\u2013006). All parents or guardians signed the informed consents and we got informed assents from all pediatric patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}